Literature DB >> 6991400

Requirement for B-lymphocyte alloantigen in the production of neutrophil migration inhibition factor from T lymphocytes (NIF-T).

R H Weisbart, R Billing.   

Abstract

Neutrophil migration inhibition factor from T lymphocytes (NIF-T) is produced in response to mitogens as the result of cellular interactions between T and B lymphocytes. The requirement for B-cell alloantigen in this interaction process was indicated by (1) collaboration between peripheral blood T cells with various B lymphoblast cell lines but not with non-B lymphoblast cells for NIF-T production, (2) inhibition of NIF-T production by treating collaborating B lymphoblasts with B-cell specific antiserum, and (3) inhibition of NIF-T production by peripheral blood lypmphocytes in the presence of anti-B-cell antiserum and F(ab')2 with anti-B-cell specificity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6991400      PMCID: PMC1458007     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

1.  Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome.

Authors:  C B Lozzio; B B Lozzio
Journal:  Blood       Date:  1975-03       Impact factor: 22.113

2.  Neutrophil migration inhibition factor from T lymphocytes (NIF-T): a new lymphokine.

Authors:  R H Weisbart; D W Golde; L Spolter; P Eggena; H Rinderknecht
Journal:  Clin Immunol Immunopathol       Date:  1979-12

3.  Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.

Authors:  J Minowada; T Onuma; G E Moore
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

4.  Autologous human B and T lymphoblastoid cell lines.

Authors:  I Royston; R W Smith; D N Buell; E S Huang; J S Pagano
Journal:  Nature       Date:  1974-10-25       Impact factor: 49.962

5.  Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji).

Authors:  M A Epstein; B G Achong; Y M Barr; B Zajac; G Henle; W Henle
Journal:  J Natl Cancer Inst       Date:  1966-10       Impact factor: 13.506

6.  Blocking of HLA and B lymphocyte alloantigens with F (ab')2 fragments of rabbit antibodies.

Authors:  R J Billing; R Honig; P Peterson; M Safani; P I Terasaki
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

7.  Lymphoblastoid transformation and kinetics of appearance of viral nuclear antigen (EBNA) in cord-blood lymphocytes infected by Epstein-Barr Virus (EBV).

Authors:  J Yata; C Desgranges; T Nakagawa; M C Favre; G De-The
Journal:  Int J Cancer       Date:  1975-03-15       Impact factor: 7.396

8.  Leukocyte inhibitory factor (LIF): production by purified human T and B lymphocytes.

Authors:  L Chess; R E Rocklin; R P MacDermott; J R David; S F Schlossman
Journal:  J Immunol       Date:  1975-07       Impact factor: 5.422

9.  A neutrophil-immobilizing factor derived from human leukocytes. I. Generation and partial characterization.

Authors:  E J Goetzl; K F Austen
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

10.  Human B-lymphocyte antigens expressed by lymphocytic and myelocytic leukemia cells. I. Detection by rabbit antisera.

Authors:  R Billing; B Rafizadeh; I Drew; G Hartman; R Gale; P Terasaki
Journal:  J Exp Med       Date:  1976-07-01       Impact factor: 14.307

View more
  1 in total

1.  Human neutrophils require activation by mononuclear leucocyte conditioned medium to kill the pathogenic free-living amoeba, Naegleria fowleri.

Authors:  A Ferrante; T J Mocatta
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.